May 12, 2020 / 11:23 AM / 15 days ago

BRIEF-Bioxcel Therapeutics Reports Q1 Loss Per Share Of $0.79

May 12 (Reuters) - BioXcel Therapeutics Inc:

* BIOXCEL THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* ENROLLMENT OF PIVOTAL SERENITY TRIALS IS PROGRESSING WELL, WITH TOPLINE DATA EXPECTED IN MID-2020

* CO IS ASSESSING DATA FOR DOSE ESCALATION IN TRANQUILITY STUDY AND IS ON TRACK TO REPORT RESULTS IN MID-2020

* QTRLY LOSS PER SHARE $0.79

* Q1 EARNINGS PER SHARE VIEW $-0.60 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below